Toxoplasmosis is one of the most common parasitic diseases worldwide and it poses a serious challenge regarding prevention, diagnosis and therapy. The commonly used diagnostic methods are mostly based on the detection of specific antibodies in sera. Since they are not always accurate enough and do not allow precise definition of the phase of the Toxoplasma gondii infection, there is an urgent need to find specific molecular markers of acute or chronic infection stages. This study provides a comparative assessment of recombinant ROP5 and ROP18 T. gondii proteins in the serodiagnosis of human toxoplasmosis. We found that both ROP5 and ROP18 proteins allowed the detection of specific IgM and IgG antibodies with a relatively low sensitivity; however, ROP18 IgM ELISA proved to be more sensitive than the SAG1 assay. This study also points to a relatively weak potential of the corresponding native ROP5 and ROP18 kinases in the generation of a strong antibody response in humans.
INTRODUCTION
Toxoplasmosis is a parasitic disease caused by the cosmopolitan protozoan Toxoplasma gondii. This single-celled parasite infects wild and domestic warm-blooded animals, as well as humans. One of the major sources of T. gondii infection is foodborne transmission, which occurs by ingesting tissue cysts from improperly cooked meat, consuming food and drinking water contaminated with oocysts or by accidental ingestion of oocysts from the environment (Jones & Dubey, 2012) . In people with a healthy immune system toxoplasmosis is often undiagnosed, because there are no signs of the disease or the symptoms are too mild to be noticeable. However, the dormant tissue cysts encapsulating T. gondii bradyzoites persist in the host organism life-long and they can rupture triggering a severe illness, especially in immunocompromised individuals (Contini, 2008) . Moreover, in pregnant women with an acute or reactivated T. gondii infection the parasites might be transplacentally transmitted to the fetus leading to the development of congenital toxoplasmosis, which can be manifested by severe complications including miscarriage and stillbirth (Kieffer & Wallon, 2013) . The outcome of the invasion depends on the gestation period; thus during the third trimester it may not display any worrying symptoms. Unfortunately, the seemingly normal development of a T. gondii-infected child might result in central nervous system disorders and retinochoroiditis later in life (Oz, 2014) .
Taking into account the serious consequences of toxoplasmosis in people with an impaired or immature immune system, an early and accurate diagnosis of T. gondii invasion is of great importance (Ciardelli et al., 2008) . The presence of the parasite can be established by the detection of specific nucleic acids (Robert-Gangneux et al., 2015) , but the routinely used diagnostic methods are mostly based on the serological recognition of specific IgG and IgM antibodies. IgM antibodies are produced during the first week of infection, preceding the synthesis of specific IgG antibodies, and usually become undetectable after a variable period of time. However, the presence of IgM cannot be taken as a sign of an early invasion, as in a number of cases they are long-lasting (Montoya, 2002) . Hence, it is required to test a new serum sample 1-3 weeks later or assess the avidity of co-existing IgG antibodies, which can usually be detected 2-3 weeks after IgM. Typically, the low avidity of IgG antibodies indicates an acute or recently acquired infection. The IgG level decreases gradually reaching a persistently detectable plateau 2-3 months post-infection (Murat et al., 2013) .
The majority of commercially available ELISA kits for detection of antibodies against T. gondii include microplates coated with a crude T. gondii antigen (TLA) derived from tachyzoites, cell cultured or propagated in mice (Glor et al., 2013) . The production of such a native antigen mixture is expensive, time-consuming and difficult to standardize. Moreover, the presence of long-lasting IgM or low-avidity IgG in the sera tested causes problems with the determination of the infection phase (Meek et al., 2001) . In an attempt to overcome these difficulties, numerous recombinant T. gondii proteins, including chimeric antigens, have been evaluated for their diagnostic usefulness and some of them have been found to be specific molecular markers of the acute or chronic stage of infection (Holec-Gąsior, 2013; Drapała et al., 2015) .
This article presents a comparative assessment of recombinant ROP5 and ROP18 T. gondii proteins in the serological recognition of human toxoplasmosis. These rhoptry proteins have been recently found to be essential parasite virulence factors (Reese et al., 2011; Jensen et al., 2015) . Both proteins belong to a prominent ROP2 protein family. They are injected into the host cell upon invasion and are subsequently bound to the membrane of the parasitophorous vacuole. Remarkably, it has been revealed that the pseudokinase ROP5 controls the catalytic activity of the active kinase ROP18, which protects T. gondii from clearance by inhibiting the immunity-related GTPases (Behnke et al., 2012; Etheridge et al., 2014) . However, the action of ROP5 and ROP18 T. gondii proteins seems to be more complex and it has been extensively studied. Other rhoptry proteins, such as ROP1 (Aubert et al., 2000; Pfrepper et al., 2005; Holec-Gąsior et al., 2009 ), ROP2 (van Gelder et al., 1993 Martin et al., 1998; Jacobs et al., 1999; Chang et al., 2011) or ROP8 (Sonaimuthu et al., 2014) , have been tested so far and proved to be promising diagnostic antigens. The question then arises, whether ROP5 or ROP18 proteins could be used for the development of novel serological tools recognizing human toxoplasmosis.
METHODS
Recombinant antigens. All experimental strategies and assays including the gene cloning, as well as the expression and purification of recombinant ROP5, ROP5-C, ROP18, ROP18-C and SAG1 proteins (Table 1) were performed as described in our previous papers (Dziadek et al., 2011; Grzybowski et al., 2015) . Standard molecular biology protocols were used for all cloning procedures (Sambrook & Russell, 2001) . Briefly, genomic DNA of T. gondii RH was used as a template for the amplification of rop5 (GenBank: HQ916451.1) and rop18 (GenBank: AM075204.1) genes and genomic DNA of T. gondii BK was used for the amplification of the sag1 gene (GenBank: S76248.1); as identified by the DNA alignment, the sag1 gene is highly homologous (99 %) in BK and RH strains of T. gondii. The sequenceverified inserts were finally subcloned into the pHIS-Parallel1 expression vector (GenBank: AF097413.1; Sheffield et al., 1999) and introduced into Escherichia coli BL21(DE3) cells. The expression of recombinant proteins was induced by adding IPTG. The protein extracts, obtained by dissolving the inclusion bodies (using urea or guanidine hydrochloride), were then purified by Ni 2+ -affinity chromatography using His-Bind columns (Novagen). The concentrations of purified proteins were quantified using the Bradford Reagent (Sigma-Aldrich). The purity of eluted proteins was analysed by SDS-PAGE combined with densitometry (FluoroChem 8800, Alpha Innotec) and it was always higher than 90 %. The results of SDS-PAGE and Western blot analyses have been demonstrated previously (Dziadek et al., 2011; Grzybowski et al., 2015) .
Toxoplasma lysate antigen. The Toxoplasma lysate antigen (TLA) was prepared as previously described (Dziadek et al., 2009 ) with minor changes. Briefly, purified tachyzoites of the T. gondii RH strain were disrupted by ten subsequent cycles of freezing-thawing in liquid nitrogen. To remove the cell debris, the resulting protein extract was centrifuged for 20 min at 10 000 g at 4 uC and then filtered with a 0.2 mm sterile nitrocellulose filter (Sartorius). The total protein concentration was measured by using the Bradford Reagent (Sigma). Aliquoted TLA samples were immediately lyophilized and stored at 220 uC. Prior to use, they were reconstituted to 1 mg ml 21 in PBS.
Detection of specific IgM and IgG antibodies. All the human serum samples tested were collected from routine diagnostic laboratories from the area of Łó d z (Poland) and classified as positive or negative based on the levels of specific IgM and IgG antibodies according to the manual of the commercial diagnostic test applied. Besides, all T. gondii-positive sera were divided based on their IgG avidity -determined either in the diagnostic laboratory or in our department using the NovaLisa Toxoplasma gondii IgG Avidity Test (NovaTec Immundiagnostica) -into an acute or a chronic phase of T. gondii infection (Table 2) . Sera considered seronegative were used as controls. Analysis of the specific IgM and IgG antibody levels was performed on a total of 146 human sera by an indirect ELISA. For this purpose, Maxisorp 96-well plates (Nunc) were coated overnight at 4 uC with recombinant or TLA (native) antigens diluted in a 0.1 M 46
Total number of sera tested 146 carbonate buffer (pH 9.5) to optimal concentrations determined in the initial experiments (10 mg ml 21 for SAG1 and TLA; 15 mg ml 21 for ROP5, ROP5-C and ROP18-C; 20 mg ml 21 for ROP18). The wells were then washed with PBS with Tween 20 (0.05 %) and blocked with skimmed milk (1 %) in PBS for 1 h at 37 uC. After another washing, the wells were incubated with human sera diluted 1 : 100 in the blocking buffer. The third washing was followed by the addition of horseradish peroxidase (HRP)-conjugated goat anti-human IgM or anti-human IgG secondary antibodies (Jackson ImmunoResearch) diluted 1 : 4000 in the blocking buffer (1 h, 37 uC). The immunoenzymic reaction was developed using ABTS (2,29-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid); Sigma) in a 0.05 M phosphate/ citrate buffer (pH 4.5) containing hydrogen peroxide (0.25 ml of 30 %, w/w, H 2 O 2 per 1 ml). The absorbance values were measured at 405 nm with a Multiscan EX automatic ELISA reader (Labsystems). All samples were run in duplicate. The optimal working dilutions of human sera and anti-human secondary antibodies were determined in the preliminary titration experiments.
Analysis of diagnostic performance. To evaluate the diagnostic potential of immunoenzymic assays based on recombinant ROP5 and ROP18 antigens, sensitivity and specificity values were estimated. The sensitivity, which refers to the ability of the test to correctly identify patients with the specific IgM/IgG antibodies, was estimated based on the formula Sensitivity5True positives/(True positives+False negatives)|100 %. The specificity, which refers to the ability to correctly identify patients without specific anti-T. gondii antibodies, was estimated based on the formula Specificity5True negatives/(True negatives+False positives)|100 %. Moreover, two global measures of diagnostic effectiveness were estimated. The diagnostic accuracy was expressed as a proportion of correctly classified subjects among all subjects: Accuracy5(True positive+True negative)/(True positive+True negative+False positive+False negative). The Youden index was calculated according to the following formula: YI5Sensitivity+Specificity-1. The Youden index ranges from 21 to 1 and the test giving the highest index is considered to have the best diagnostic performance (Okeh & Ogbonna, 2013) . 
RESULTS

Analysis of immunoreactivity
We examined a total of 146 human sera to detect specific IgM and IgG antibodies using selected recombinant (ROP5, ROP5-C, ROP18, ROP18-C, SAG1) or native (TLA) T. gondii antigens ( Table 2 ). Due to the common application of TLA and SAG1 (p30) antigens in commercial diagnostic tests detecting toxoplasmosis, we used them for comparative purposes.
As shown in Fig. 1 , in the group of patients with suspected acute T. gondii infection, all recombinant antigens tested reacted with IgM antibodies more weakly than with TLA (0.0000001jPj0.000085). In the groups of patients with chronic infection (IgM + or IgM -) the level of anti-TLA IgM antibodies detected was higher as compared with other antigens tested (P50.0000001) except for ROP18 (P51.000). In all groups of T. gondii-positive patients, the levels of anti-SAG1 IgM antibodies were significantly lower than those of anti-ROP18 IgM antibodies (0.000044jPj0.000271). The strongest IgG signals were observed using TLA, no matter in which group of patients (0.0000001jPj0.000121), but no significant differences were detected between anti-SAG1 and anti-ROP5 (0.856jPj1.000) or anti-ROP18 (0.0615jPj1.000) IgG antibody levels. In a general observation, the weakest absorbance values were measured for C-terminal fragments of ROP5 and ROP18 proteins.
Additionally, an analysis of IgM/IgG ratios (Table 3) revealed that regardless of the infection phase and in contrast to ROP5, SAG1 and TLA, the native ROP18 protein triggers a balanced IgM/IgG antibody response. In the case of other antigens tested a significant predominance of IgG was observed.
Evaluation of diagnostic value
The IgM cut-off point calculated (Table 4) was significantly higher for the TLA compared with the other antigens tested (0.0000001jPj0.0187). There were no differences between ROP5 and ROP18 (P51.000) or ROP5-C and ROP18-C (P51.000). In ROP5 and ROP18 IgG ELISAs the absorbance values obtained for normal sera were not significantly different compared with those for TLA (P50.864 and P51.000, respectively). The differences between ROP5 and ROP18, as well as ROP5-C and ROP18-C, were not significant (P51.000 and P50.895, respectively).
The overall analysis of the diagnostic performance of indirect ELISAs applied (Table 5) confronted with a commercial reference assay revealed that the most accurate test was the one with TLA (100 % accuracy for IgG and 91 % for IgM detection). The SAG1 ELISA was less sensitive than the TLA test (IgG by 7 % and IgM by 37 %). Both, ROP5 and ROP18 ELISAs were more accurate for IgM detection compared with IgG detection (by 21 % and 20 %, respectively). Moreover, the IgM ELISA was more sensitive using ROP18 than the dominant surface SAG1 antigen (by 19 %). The high reactivity of the recombinant ROP18 antigen in IgM ELISA was significantly compatible with a reference diagnostic test (x 2 517.13, P50.00001).
DISCUSSION
T. gondii is considered as one of the most successful parasites worldwide. This success may be attributed to its cosmopolitism and the ability to infect virtually every warm-blooded animal, as well as humans. Although most infections in people are asymptomatic, T. gondii poses a serious threat to immunocompromised people, including patients with HIV or cancer, as well as a growing group of transplant recipients and other immunosuppressed individuals. Moreover, congenital infections lead to a wide spectrum of severe disorders during pregnancy. Apart from the purely medical aspects, human toxoplasmosis has a great socioeconomic impact, since costs of the healthcare of ill people, especially children with mental retardation or ocular disease, are enormous (Hill & Dubey, 2002) . This implies an urgent need to develop precise diagnostic tools not only for detecting the T. gondii invasion, but also for distinguishing its phase, since more accurate recognition of the infection status means better overall control of the disease.
Currently used diagnostic tests based on TLA are sensitive but also affected by some disadvantages, such as difficulties in the estimation of the actual infection time. Furthermore, contamination with a non-parasitic material from the culture and batch-to-batch variations make these tests difficult to standardize. To overcome these drawbacks, various recombinant T. gondii antigens have been developed so far and tested for their diagnostic usefulness in Western blot or ELISAs (Kotresha & Noordin, 2010; Holec-Gąsior, 2013) . Among numerous surface and secretory antigens tested, rhoptry proteins have been found to be very interesting research objects and promising diagnostic tools (Saavedra et al., 1991; van Gelder et al., 1993; Martin et al., 1998; Holec-Gąsior et al., 2009; Gatkowska et al., 2010) . The aim of this study was to determine the potential diagnostic value of two dominant T. gondii virulence factors (Niedelman et al., 2012 ) -ROP5 and ROP18 kinases.
Our previous study carried out on T. gondii-infected mice (Grzybowski et al., 2015) suggested that the immune response to native ROP5 and ROP18 proteins differs from a typical antibody response observed for the SAG1 antigen (Gatkowska et al., 2006) . Infection with T. gondii triggered a humoral response against ROP5 and ROP18 with noticeable predominance of IgM antibodies. Hence, we supposed that anti-ROP IgM antibodies might serve as an early and sensitive marker of T. gondii infection. *The cut-off score was determined by adding a doubled value of standard deviation to the mean absorbance calculated for the control group consisting of T. gondii-negative patients. To verify this assumption, we tested 146 human sera for the presence of specific anti-ROP5 and anti-ROP18 antibodies, collected from ambulatory patients with a defined T. gondii infection status. Contrary to the earlier study on mice, we did not observe any predominance of IgM antibodies in people with toxoplasmosis. However, the highest IgM/ IgG ratios were noticed for ROP18 and ROP18-C ELISAs. These results reflect the outcomes of our previous study on ROP2 and ROP4 proteins (Gatkowska et al., 2010) , other members of the prominent ROP2-family. As in the case of ROP5 and ROP18 (Grzybowski et al., 2015) , Gatkowska et al. (2010) demonstrated a preferential synthesis of anti-ROP2 and anti-ROP4 IgM antibodies in mice, but, remarkably, testing of human sera with high IgG avidity or antibody pattern typical for latent toxoplasmosis revealed no specific antibodies against either ROP2 or ROP4 recombinant antigens. Moreover, out of seven sera classified as acute phase-associated, only one sample tested showed considerable amounts of IgM antibodies against ROP2 and ROP4 (our unpublished data). Such weak reactivity may result from probable discrepancies in the actual infection status at the time of blood collection or gradual disappearance of anti-ROP antibodies while the infection is becoming chronic, as observed in the murine model. Besides, the poor sensitivity of ROP5-or ROP18-based assays may be influenced by the differences in their expression levels in various T. gondii strains which can infect humans. It might also be explained by the recombinant proteins' inability to bind efficiently the host-synthetized antibodies (Aubert et al., 2000) . In the case of humans, who are innately equipped with diverse major histocompatibility complex (MHC) molecules, some of the individuals could be lacking particular MHC molecules capable of presenting individual antigen epitopes (Tan et al., 2010) .
Furthermore, the analysis of diagnostic usefulness performed for the recombinant ROP5 and ROP18 antigens revealed rather poor sensitivity as compared with that of TLA, especially in IgG ELISAs, but noteworthy, the ROP18 IgM ELISA had higher sensitivity and overall accuracy scores than IgM ELISA based on the main tachyzoite surface SAG1 (p30) antigen, which is used in some commercial tests (Roux-Buisson et al., 2005) .
Still very little is known about the immune response to ROP5 and ROP18 proteins during natural T. gondii infection. Our study reports for the first time to our knowledge the immunogenic properties of native ROP5 in terms of the antibody response in humans. In a recent study, Sán-chez et al. (2014) attempted to serotype patients with ocular toxoplasmosis using synthetic ROP18 peptides specific for the three major T. gondii clonal lineages. These ROP18-derived peptides revealed sensitivity ranging from 16.6 % to 33 %. The research was continued by Torres-Morales et al. (2014) , who revealed that the native sequences of ROP18, corresponding to the ones tested previously, are indeed immunogenic in humans since they induce the T-cell-mediated immunity.
To summarize, our findings demonstrate that recombinant ROP5 and ROP18 proteins allow the detection of specific IgM and IgG antibodies with a relatively low sensitivity, suggesting a weak potential of the corresponding native kinases for the generation of a robust antibody response in humans. However, we suppose that the application of full-length forms of these proteins in combination with other T. gondii antigens might improve the accuracy of newly constructed diagnostic tests. We also believe that further studies aimed at the identification of ROP5 and ROP18 immunodominant epitopes will be of great importance and will enable the construction of chimeric antigens designed for diagnostic purposes.
